Device innovations, demographics and hospital austerity are all factors helping to drive the global medical device market to more than $300 billion, according to healthcare market research publisher Kalorama Information. In its report, " The Global Market for Medical Devices," Kalorama Informations analysts predict a $312 billion medical device market in 2011.
"There are many drivers on the upside for medical devices," says Kalorama Informations publisher, Bruce Carlson. "Demand for healthcare services in emerging nations, the need for reducing hospital stays and the aging world population are the key ones."
The market for medical devices is vast and, in Kalorama Informations report, products as different as complex MRI machines, laparoscopic surgical equipment, wheelchairs and medical gloves are included in the category.
Kalorama sees roughly 4 percent to 6 percent growth for the next few years in the global device market, which was valued at $290 billion in 2009. Growth has been slow the past few years, according to the report, given the world recession. But as the economy recovers and new middle class customers in emerging markets demand better healthcare services, the report predicts the pace of revenue growth to increase. According to Carlson, the average growth rate belies that in some categories growth is much higher than the average discussed in the report.
"Some categories of medical devices are commoditized and competition will hold prices in check, while in other areas revenues will flourish," Carlson says. "Patient monitoring, oxygen systems, home dialysisanything that can reduce hospital stays and keep patients at home with their familyare seeing faster revenue growth."
There are hundreds of companies operating in the global medical device market, but according to the report, the majority of revenues will be earned by 30 of the top companies, among them: Johnson & Johnson, Siemens Healthcare, Medtronic, GE Healthcare and Baxter.
Kalorama Informations estimates are based on industry interviews, a review of the firms own previous research into specific device markets and annual reports of major companies.
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.